查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000623

冠狀動脈疾病診斷影像設備市場：按技術、應用和最終用戶分類 - 2026-2032年全球市場預測

Coronary Heart Disease Diagnostic Imaging Devices Market by Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，冠狀動脈疾病影像診斷設備市場價值將達到 28.4 億美元，到 2026 年將成長至 31.3 億美元，到 2032 年將達到 58.2 億美元，複合年成長率為 10.79%。

主要市場統計數據
基準年 2025 28.4億美元
預計年份：2026年 31.3億美元
預測年份 2032 58.2億美元
複合年成長率 (%) 10.79%

從綜合觀點探討冠狀動脈疾病的影像診斷，重點在於技術、臨床工作流程和數據驅動決策的整合。

冠狀動脈疾病的診斷越來越依賴一系列先進的影像技術，這些技術能夠比單一技術更全面、更細緻地呈現臨床影像。過去十年，影像技術已從單純的解剖結構簡介發展到整合結構、功能和分子資訊的綜合評估，從而指導精準醫療。因此，臨床醫生、醫院系統和供應商如今所處的環境，決定著設備間互通性、影像分析和工作流程整合的可行性，而這些因素既影響臨床療效，也影響商業性可行性。

人工智慧、混合成像、安全最佳化和基於價值的採購方面的進步如何從根本上改變診斷過程和供應商競爭。

冠狀動脈疾病診斷影像領域正受到多種因素的共同影響，這些因素正在改變臨床醫生檢測、量化和監測疾病的方式。人工智慧和先進的影像分析技術正從先導計畫走向臨床工作流程，實現斑塊自動表徵、灌注定量和分診優先排序，從而縮短解讀時間並提高結果的可重複性。同時，結合解剖和功能資訊的混合和多模態成像策略，例如CT衍生的血流儲備分數和PET/CT聯合通訊協定，正在提高診斷的準確性並減少對侵入性血管造影術的依賴。

本研究評估了基於關稅的採購壓力、供應鏈重組和成本轉嫁趨勢如何影響醫療設備的設計、分銷和臨床部署。

美國當年加徵的關稅對診斷影像技術的採購、製造策略和經濟效益產生了連鎖反應。進口零件關稅導致成本上升，促使製造商重新評估其全球籌資策略，加快供應商多元化，並在許多情況下探索關鍵子組件的近岸外包或國內生產。這些供應鏈調整改變了前置作業時間、資本配置以及不同診斷影像平台之間的相對成本競爭力。

將設備架構、臨床用例和醫療保健需求聯繫起來的詳細細分分析揭示了精確的採用因素和技術適用性。

一套精細的細分框架揭示了臨床需求、技術能力和購買行為之間的交集，有助於明確產品策略和市場進入計劃。按技術分類，該領域包括電腦斷層掃描 (CT)、磁振造影(MRI)、光學成像、正子斷層掃描 (PET)、單光子發射電腦斷層掃描 (SPECT) 和超音波。特別是電腦斷層掃描 (CT)，其架構可分為雙源 CT、多切面CT 和單切片電腦斷層掃描器等，每種架構都會在時間解析度、空間解析度和吞吐量之間做出不同的權衡。磁振造影(MRI) 則進一步細分為 1.5 特斯拉、3 特斯拉和 3 特斯拉以上磁場強度類別，這些類別會影響訊號雜訊比、掃描速度以及對高階組織特性分析通訊協定的適用性。光學成像技術包括血管內成像方式，例如血管內光學同調斷層掃描和近紅外線光譜，這些技術透過評估斑塊的微觀結構和成分，對大血管成像起到補充作用。超音波系統在2D平台、3D容積成像和多普勒功能方面各不相同，可用於量化血流動力學。

區域醫療保健基礎設施、報銷制度和臨床重點如何影響全球市場診斷影像技術的部署模式？

受醫療基礎設施、法規環境和支付模式差異的影響，區域趨勢塑造了創新軌跡和臨床應用速度。在美洲，對三級醫療的大量資本投入以及對微創治療路徑的高度重視，推動了對先進電腦斷層掃描（CT）、高場磁振造影（MRI）系統和混合成像解決方案的需求，這些方案能夠減少不必要的侵入性診斷。從大學醫院到社區醫院和門診診所，人們對能夠將診斷能力擴展到傳統醫院框架之外的攜帶式、經濟高效的診斷設備也表現出濃厚的興趣。

為什麼企業正從以硬體為中心的銷售模式轉向整合軟體、服務和臨床證據的整合平台，以確保與醫療機構建立長期夥伴關係？

冠狀動脈診斷影像領域的企業策略正趨向於一系列實際需求：平台模組化、透過服務和軟體實現持續收入、臨床證據的累積以及策略夥伴關係。領先的製造商不再局限於硬體，而是提供基於雲端的分析、承包安裝和維護合約以及臨床醫生培訓項目，從而縮短產品實現臨床價值所需的時間。這種轉變反映出人們意識到，長期的客戶關係和數據驅動的服務往往比一次性的設備銷售更能帶來更高的客戶終身價值。

為了加快推廣應用，我們為供應商和醫療保健系統制定了具體的策略重點，以平衡創新、價值鏈韌性和基於價值的商業模式。

產業領導企業應採取多管齊下的策略，重點關注臨床結果、營運韌性和靈活的商業模式，以最大限度地提高產品普及率和長期價值。首先，他們應優先投資於人工智慧驅動的影像分析和工作流程自動化，以顯著縮短解讀時間和降低放射科醫生之間的差異。先導計畫的設計應旨在獲取臨床終點和經濟效益數據，從而為報銷談判和採購核准奠定基礎。其次，他們應重新設計產品系列，並專注於模組化。這將允許透過更換軟體和模組化硬體來升級核心平台，而不是完全更換設備，從而在減少採購摩擦的同時，維護客戶關係。

採用嚴謹的混合方法研究框架，結合臨床醫師訪談、技術文件審查、供應鏈映射和情境分析，以檢驗策略結論。

本分析整合了多種證據來源，以確保方法論的嚴謹性和實務有效性。主要調查包括對臨床醫生、採購經理和醫療設備工程師進行結構化訪談，以收集有關臨床需求、採購限制和技術偏好的第一手資訊。除這些訪談外，專家諮詢小組的檢驗也支持了諸如人工智慧整合、混合成像實施以及貿易政策變化對營運的影響等新興主題。次要分析則利用同儕審查文獻、監管文件、醫療設備技術規格和已發布的臨床指南，全面檢驗了跨模態性能特徵和臨床效用。

結論強調需要將臨床檢驗、模組化產品策略和服務主導的商業性方法結合起來，以創造長期價值。

總而言之，冠狀動脈疾病診斷影像生態系統正處於轉折點，透過技術成熟度、數據分析和不斷演進的採購模式，重新定義臨床路徑。最成功的方案是將高清顯像模式與人工智慧驅動的分析、模組化升級以及使供應商獎勵與臨床結果一致的服務模式相結合。貿易政策的波動和區域基礎設施的差異既帶來風險也帶來機遇，從而促進供應鏈韌性和區域性客製化策略的發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：冠狀動脈疾病診斷影像設備市場：依技術分類

  • CT
    • 雙源CT
    • 多切面CT
    • 單切片電腦斷層掃描器
  • MRI
    • 1.5T
    • 3T
    • 3噸或以上
  • 光學成像
    • IVOCT
    • NIRS
  • PET
  • SPECT
  • 超音波
    • 2D
    • 3D
    • 多普勒

第9章：冠狀動脈疾病診斷影像設備市場：依應用領域分類

  • 解剖學評估
  • 灌注影像
    • 靜止狀態下的灌注
    • 負荷下灌注
  • 生物醫學影像

第10章：冠狀動脈疾病診斷影像設備市場：依最終使用者分類

  • 門診部
  • 診斷中心
  • 醫院
  • 專科診所

第11章：冠狀動脈疾病診斷影像設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：冠狀動脈疾病診斷影像設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：冠狀動脈疾病診斷影像設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國冠狀動脈疾病診斷影像設備市場

第15章：中國冠狀動脈疾病診斷影像設備市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert Group
  • Analogic Corporation
  • AngioDynamics, Inc.
  • Canon Medical Systems Corporation
  • Chison Medical Technologies Co., Ltd.
  • Edwards Lifesciences Corporation
  • Epsilon Imaging, Inc.
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Heart Test Laboratories, Inc.
  • Hill-Rom Holdings, Inc.
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • LivaNova PLC
  • Merit Medical Systems, Inc.
  • Mindray Medical International Limited
  • Siemens AG
  • Terumo Medical Corporation
  • TOMTEC Imaging Systems GmbH
  • Toshiba Corporation
  • Translumina GmbH
Product Code: MRR-8C74ADFC03A3

The Coronary Heart Disease Diagnostic Imaging Devices Market was valued at USD 2.84 billion in 2025 and is projected to grow to USD 3.13 billion in 2026, with a CAGR of 10.79%, reaching USD 5.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.84 billion
Estimated Year [2026] USD 3.13 billion
Forecast Year [2032] USD 5.82 billion
CAGR (%) 10.79%

An integrative perspective on coronary heart disease diagnostic imaging that highlights the convergence of technology, clinical workflows, and data-driven decision making

The diagnosis of coronary heart disease increasingly relies on an array of advanced imaging modalities that together create a richer, more nuanced clinical picture than any single technique could provide alone. Over the last decade, imaging has shifted from standalone anatomical snapshots to integrated assessments that combine structural, functional, and molecular information to guide precision care. As a result, clinicians, hospital systems, and technology vendors now operate in an environment where device interoperability, image analytics, and workflow integration determine both clinical impact and commercial viability.

In clinical practice, the imperative is clear: deliver faster, more accurate diagnosis while minimizing patient risk and streamlining care pathways. Technological advances, regulatory rigor, and evolving reimbursement practices are converging to reward solutions that shorten time to diagnosis, reduce unnecessary invasive procedures, and enable longitudinal disease management. This introduction frames the remainder of the executive summary by emphasizing that successful market actors will be those who align engineering innovation with clinical utility, workflow optimization, and data-driven decision support.

Consequently, stakeholders must understand not only the capabilities of individual imaging platforms but also how they function within complex care ecosystems. From point-of-care ultrasound that improves bedside triage to high-resolution computed tomography that informs interventional planning, each modality contributes to a continuum of care. The subsequent sections synthesize transformative trends, trade policy impacts, segmentation nuances, regional variations, corporate strategies, and practical recommendations that together chart a pathway for leaders in coronary heart disease diagnostic imaging.

How advances in artificial intelligence, hybrid imaging, safety optimization, and value-based procurement are fundamentally reshaping diagnostic pathways and vendor competition

The landscape of coronary heart disease diagnostic imaging is being reshaped by several convergent forces that are transforming how clinicians detect, quantify, and monitor disease. Artificial intelligence and advanced image analytics have moved from pilot projects into clinical workflows, enabling automated plaque characterization, perfusion quantification, and triage prioritization that reduce interpretation time and enhance reproducibility. Simultaneously, hybrid and multimodal imaging strategies that pair anatomical and functional information-such as computed tomography-derived fractional flow reserve and combined PET/CT protocols-are increasing diagnostic confidence and reducing the reliance on invasive angiography.

Another pivotal shift is the relentless drive toward dose reduction and patient safety. Innovations in reconstruction algorithms, detector design, and contrast usage are allowing for high-fidelity images at markedly lower radiation and contrast loads, which broadens the suitability of advanced imaging for frail and comorbid populations. At the same time, the emergence of point-of-care and compact systems, particularly in ultrasound and lower-field MR, is decentralizing diagnostics and enabling faster decision-making in ambulatory and emergency settings.

Operationally, payers and health systems are accelerating adoption of value-based procurement models that prioritize outcomes, throughput, and total cost of care. This is prompting vendors to offer bundled service contracts, performance guarantees, and cloud-enabled subscription services. Finally, global supply chain optimization and localized manufacturing are becoming strategic imperatives as vendors seek resilience against geopolitical disruption and cost volatility. In combination, these shifts are expanding clinical capability while intensifying competition around integration, scalability, and demonstrable clinical value.

Assessing how tariff-driven procurement pressures, supply chain realignments, and cost pass-through dynamics are influencing device design, distribution, and clinical adoption

United States tariff measures implemented in the year in question have had a cascading impact on procurement, manufacturing strategies, and the economics of diagnostic imaging technologies. Tariff-induced cost increases for imported components prompted manufacturers to reassess global sourcing strategies, accelerate supplier diversification, and in many cases explore nearshoring or domestic production for critical subassemblies. These supply chain adaptations have altered lead times, capital allocation, and the relative cost competitiveness of different imaging platforms.

As procurement costs rose for certain imported devices and parts, healthcare providers and integrated delivery networks intensified scrutiny of total cost of ownership, favoring systems that promised long-term serviceability, remote diagnostics, and modular upgrade paths. In parallel, some vendors absorbed tariff-related expenses to protect their market positioning, while others passed incremental costs to purchasers, creating differential pricing pressure across hospitals, diagnostic centers, and ambulatory settings.

Tariffs also influenced innovation pathways. Budgetary constraints and procurement unpredictability pushed OEMs toward platform designs that reduced reliance on tariff-exposed components and emphasized software-driven differentiation. Regulatory interactions shifted as well, with companies prioritizing devices and modifications that offered quick, high-value clinical returns within constrained capital cycles. Finally, trade policy fostered strategic partnerships between manufacturers and regional distributors to mitigate customs complexity and to establish more predictable contractual arrangements. Taken together, these effects underscore that trade measures can accelerate structural change across the industry by catalyzing supply chain resilience, design modularity, and commercial flexibility.

Detailed segmentation analysis linking device architectures, clinical use cases, and care setting requirements to reveal precise adoption drivers and technology fit

A nuanced segmentation framework reveals where clinical demand intersects with technological capability and purchasing behavior, providing clarity for product strategy and go-to-market planning. When examined by technology, the field comprises computed tomography, magnetic resonance imaging, optical imaging modalities, positron emission tomography, single-photon emission computed tomography, and ultrasound. Computed tomography in particular is differentiated by architectures such as dual-source CT, multi-slice CT, and single-slice CT, each offering distinct trade-offs between temporal resolution, spatial resolution, and throughput. Magnetic resonance imaging is further stratified by field strength categories of one point five tesla, three tesla, and above three tesla, which influence signal-to-noise, acquisition speed, and suitability for advanced tissue characterization protocols. Optical imaging techniques include intracoronary modalities such as intravascular optical coherence tomography and near-infrared spectroscopy, which provide microstructural and compositional plaque assessment that complements macrovascular imaging. Ultrasound systems vary across two-dimensional platforms, three-dimensional volumetric imaging, and Doppler capabilities that quantify flow dynamics.

Looking through the lens of end users, adoption patterns diverge across ambulatory care centers, diagnostic centers, hospitals, and specialty clinics, with each setting prioritizing a different mix of capital intensity, throughput, and clinical flexibility. Diagnostic objectives cluster into anatomical assessment, perfusion imaging, and viability imaging, where perfusion protocols themselves bifurcate into resting perfusion and stress perfusion paradigms that drive different hardware and software requirements. Understanding these segments together illuminates the trade-offs clinicians and procurement teams weigh: speed versus precision, portability versus comprehensive capability, and capital expenditure versus per-scan economics. Consequently, vendors and health systems that map product features to specific clinical workflows and procurement constraints will achieve clearer differentiation and higher adoption velocity.

How regional healthcare infrastructure, reimbursement frameworks, and clinical priorities are driving divergent adoption models for diagnostic imaging across global markets

Regional dynamics are shaping both the trajectory of innovation and the pace of clinical uptake, driven by variations in healthcare infrastructure, regulatory environments, and payer models. In the Americas, high levels of capital investment in tertiary centers and a strong emphasis on minimally invasive care pathways are driving demand for advanced computed tomography, high-field magnetic resonance systems, and hybrid imaging solutions that reduce unnecessary invasive diagnostics. Transitioning from academic centers to community hospitals and ambulatory settings, there is also significant interest in portable, cost-effective modalities that can extend diagnostic capability outside traditional hospital walls.

Europe, Middle East & Africa exhibits considerable heterogeneity: established Western European healthcare systems are rapidly adopting dose-reduction technologies and AI-enabled analytics, while parts of the Middle East prioritize flagship tertiary investments and emerging clinical networks. In Africa, the imperative often centers on access and reliability, pushing adoption toward robust, low-maintenance systems and tele-radiology partnerships that can amplify limited specialist capacity. Reimbursement structures and cross-border regulatory harmonization in this region exert a strong influence on procurement cycles and vendor strategies.

Asia-Pacific continues to be a dynamic growth arena, propelled by large population bases, expanding middle-class demand for advanced diagnostics, and national investments in healthcare infrastructure. Regional manufacturers and international OEMs compete aggressively on service models, price-performance ratios, and local partnerships. Across all regions, interoperability, cloud-enabled image sharing, and training programs remain central to adoption, but the balance between high-end tertiary investments and decentralized diagnostic access varies significantly by geography, shaping distinct commercial approaches.

Why companies are shifting from hardware-centric sales to integrated platforms that combine software, services, and clinical evidence to secure long-term institutional partnerships

Corporate strategies within the coronary diagnostic imaging arena are converging around a set of practical imperatives: platform modularity, recurring revenue through service and software, clinical evidence generation, and strategic partnerships. Leading manufacturers are expanding beyond hardware to offer cloud-enabled analytics, turnkey installation and maintenance contracts, and clinician training programs that accelerate time to clinical value. This shift reflects an understanding that long-term customer relationships and data-driven services often yield higher lifetime value than one-time equipment sales.

Mergers, strategic alliances, and targeted acquisitions continue to be a primary route for companies seeking rapid entry into complementary technologies, such as AI startups focused on plaque detection or specialist firms developing coronary perfusion quantification software. Additionally, strategic investors are placing emphasis on companies that demonstrate clear clinical outcomes, regulatory clearance pathways, and scalable deployment models for varied care settings. Service differentiation increasingly includes remote monitoring of system health, predictive maintenance, and outcome-linked contracting that aligns vendor incentives with institutional goals.

Finally, competition for talent-engineers, clinical specialists, and regulatory experts-is shaping innovation pipelines. Organizations that combine clinical domain expertise with software and cloud engineering capabilities are better positioned to deliver integrated solutions that meet the needs of multi-disciplinary cardiac teams. As a result, product roadmaps now commonly reflect a combination of hardware improvements, modular software upgrades, and ecosystem partnerships aimed at delivering measurable improvements in diagnostic accuracy, workflow efficiency, and patient experience.

Actionable strategic priorities for vendors and health systems that balance innovation, supply chain resilience, and value-based commercial models to accelerate adoption

Industry leaders should adopt a multi-pronged strategy that emphasizes clinical outcomes, operational resilience, and flexible commercial models to maximize adoption and long-term value. First, prioritize investments in AI-driven image analysis and workflow automation that demonstrably reduce interpretation time and inter-reader variability; pilot projects should be designed to capture clinical endpoints and economic benefits to enable reimbursement discussions and procurement approvals. Second, redesign product portfolios to emphasize modularity, enabling core platforms to be upgraded via software or modular hardware swaps rather than full capital replacement, which preserves customer relationships and reduces procurement friction.

Third, strengthen supply chain resilience by diversifying suppliers, qualifying alternative component sources, and evaluating nearshoring options for critical manufacturing steps. These measures will reduce exposure to tariff volatility and logistical disruption while improving lead time predictability for customers. Fourth, expand service and subscription offerings that bundle analytics, uptime guarantees, and training, thereby creating recurring revenue streams and aligning vendor incentives with clinical and operational outcomes. Fifth, pursue targeted partnerships with health systems and payers to generate real-world evidence that supports value-based contracting and to create joint pilots that illustrate reduced invasive procedural rates or improved patient throughput.

Finally, tailor go-to-market approaches by region and care setting, recognizing the different procurement drivers across tertiary hospitals, diagnostic centers, ambulatory care sites, and specialty clinics. Investments in clinician education, tele-radiology networks, and local service capabilities will accelerate adoption in markets with constrained specialist availability, while bundled offerings and outcome guarantees will resonate in systems prioritizing total cost of care.

A rigorous mixed-methods research framework combining clinician interviews, technical dossier review, supply chain mapping, and scenario analysis to validate strategic conclusions

This analysis synthesizes multiple evidence streams to ensure methodological rigor and practical relevance. Primary research included structured interviews with clinicians, procurement leaders, and device engineers to capture frontline insights into clinical requirements, procurement constraints, and technology preferences. These conversations were complemented by expert advisory panels that validated emerging themes such as AI integration, hybrid imaging adoption, and the operational impact of trade policy changes. Secondary analysis drew upon peer-reviewed literature, regulatory filings, device technical specifications, and published clinical guidelines to triangulate performance characteristics and clinical utility across modalities.

To understand commercial and supply chain implications, the research incorporated qualitative supplier mapping, contract review summaries, and scenario analysis of tariff and logistics disruptions. Product roadmaps and patent trends were examined to identify areas of technological differentiation and potential competitive entry points. Finally, findings were stress-tested through scenario planning workshops that modeled adoption pathways across different reimbursement and investment environments, providing robust directional guidance for stakeholders seeking to align product strategy with clinical demand and procurement realities.

Concluding synthesis that underscores the imperative to align clinical validation, modular product strategy, and service-led commercial approaches to capture long-term value

In summary, the diagnostic imaging ecosystem for coronary heart disease is at an inflection point where technological maturity, data analytics, and changing procurement models are collectively redefining clinical pathways. The most successful approaches will integrate high-fidelity imaging modalities with AI-enabled analysis, modular upgradeability, and service models that align vendor incentives with clinical outcomes. Trade policy fluctuations and regional differences in infrastructure create both risk and opportunity, incentivizing supply chain resilience and tailored regional strategies.

Stakeholders-from device manufacturers to hospital executives-must therefore prioritize investments that reduce time to diagnosis, lower procedural risk, and demonstrably improve patient outcomes while maintaining operational flexibility. By focusing on modular platforms, evidence-generation partnerships, and recurrent service revenues, organizations can build defensible positions in a market increasingly driven by interoperability and value-based procurement. The overarching conclusion is clear: combining clinical validation with scalable commercial models will determine who leads the next wave of diagnostic innovation in coronary care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Heart Disease Diagnostic Imaging Devices Market, by Technology

  • 8.1. CT
    • 8.1.1. Dual-Source CT
    • 8.1.2. Multi-Slice CT
    • 8.1.3. Single-Slice CT
  • 8.2. MRI
    • 8.2.1. 1.5T
    • 8.2.2. 3T
    • 8.2.3. Above 3T
  • 8.3. Optical Imaging
    • 8.3.1. IVOCT
    • 8.3.2. NIRS
  • 8.4. PET
  • 8.5. SPECT
  • 8.6. Ultrasound
    • 8.6.1. 2D
    • 8.6.2. 3D
    • 8.6.3. Doppler

9. Coronary Heart Disease Diagnostic Imaging Devices Market, by Application

  • 9.1. Anatomical Assessment
  • 9.2. Perfusion Imaging
    • 9.2.1. Resting Perfusion
    • 9.2.2. Stress Perfusion
  • 9.3. Viability Imaging

10. Coronary Heart Disease Diagnostic Imaging Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals
  • 10.4. Specialty Clinics

11. Coronary Heart Disease Diagnostic Imaging Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Coronary Heart Disease Diagnostic Imaging Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Coronary Heart Disease Diagnostic Imaging Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Coronary Heart Disease Diagnostic Imaging Devices Market

15. China Coronary Heart Disease Diagnostic Imaging Devices Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Agfa-Gevaert Group
  • 16.6. Analogic Corporation
  • 16.7. AngioDynamics, Inc.
  • 16.8. Canon Medical Systems Corporation
  • 16.9. Chison Medical Technologies Co., Ltd.
  • 16.10. Edwards Lifesciences Corporation
  • 16.11. Epsilon Imaging, Inc.
  • 16.12. FUJIFILM Corporation
  • 16.13. GE HealthCare Technologies Inc.
  • 16.14. Heart Test Laboratories, Inc.
  • 16.15. Hill-Rom Holdings, Inc.
  • 16.16. Hitachi, Ltd.
  • 16.17. Koninklijke Philips N.V.
  • 16.18. LivaNova PLC
  • 16.19. Merit Medical Systems, Inc.
  • 16.20. Mindray Medical International Limited
  • 16.21. Siemens AG
  • 16.22. Terumo Medical Corporation
  • 16.23. TOMTEC Imaging Systems GmbH
  • 16.24. Toshiba Corporation
  • 16.25. Translumina GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DUAL-SOURCE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MULTI-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SINGLE-SLICE CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 1.5T, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3T, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ABOVE 3T, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY IVOCT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY NIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 2D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY 3D, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ANATOMICAL ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY RESTING PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY STRESS PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY VIABILITY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 174. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 175. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 176. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 177. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 179. GCC CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 203. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 204. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. G7 CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 213. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 215. NATO CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY MRI, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY OPTICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY PERFUSION IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA CORONARY HEART DISEASE DIAGNOSTIC IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)